Literature DB >> 10469278

Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment.

P C Schiller1, G D'Ippolito, B A Roos, G A Howard.   

Abstract

We have investigated signaling (cAMP) and anabolic responses (mineralization of extracellular matrix [ECM]) to parathyroid hormone (PTH) in long-term (30 days) cultures of MC3T3-E1 cells, a murine model of osteoblast differentiation. Expression of PTH/PTH-related peptide receptor (PTH1R) mRNA is detected early and remains relatively constant for 2 weeks with somewhat higher levels observed during the second half of the culture period. In contrast to the relatively stable PTH1R mRNA expression, the cAMP response to PTH varies markedly with no response at day 5 and a marked response (80-fold versus control) by day 10. Responsiveness to PTH remains elevated with fluctuations of 30- to 80-fold stimulation throughout the remainder of the culture period. The timing and duration of PTH treatment to achieve in vitro mineralization of ECM was evaluated. When continuous PTH treatment was initiated before day 20, mineralization decreased. If continuous PTH treatment began on or after day 20, mineralization was unaffected. However, if treatment began on day 20 and then stopped on day 25, mineralization on day 30 was increased 5-fold. This mineralization response to intermittent PTH was confirmed in primary cultures of murine and human osteoblastic cells. These data provide a potential basis for understanding the differential responses to PTH (anabolic versus catabolic) and indicate the developmental temporal variance of anabolic and catabolic responses. Since cAMP signaling was relatively unchanged during this interval (day 10-30) and stimulation of adenylate cyclase only partially mimicked the PTH effect on increased mineralization, other signaling pathways are likely to be involved in order to determine the specific anabolic response to short-term PTH treatment during the differentiation process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469278     DOI: 10.1359/jbmr.1999.14.9.1504

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

2.  Connective tissue growth factor (CTGF/CCN2) negatively regulates BMP-2 induced osteoblast differentiation and signaling.

Authors:  Christina Mundy; Maureen Gannon; Steven N Popoff
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

3.  Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells.

Authors:  Mei Zhang; Parmeet K Manchanda; Dayong Wu; Qianben Wang; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2014-02-07

4.  Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow.

Authors:  Christian E Jacome-Galarza; Sun-Kyeong Lee; Joseph A Lorenzo; Hector Leonardo Aguila
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

5.  The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization.

Authors:  Kevin W-H Lo; Ho Man Kan; Keshia M Ashe; Cato T Laurencin
Journal:  J Tissue Eng Regen Med       Date:  2011-02-10       Impact factor: 3.963

6.  Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.

Authors:  Chandrika D Mahalingam; Tanuka Datta; Rashmi V Patil; Jaclynn Kreider; R Daniel Bonfil; Keith L Kirkwood; Steven A Goldstein; Abdul B Abou-Samra; Nabanita S Datta
Journal:  J Endocrinol       Date:  2011-08-18       Impact factor: 4.286

7.  The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.

Authors:  Antonio Casado-Diaz; Raquel Santiago-Mora; José Manuel Quesada
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

8.  Expression of Rho GDIalpha in rat osteoblasts intermittently exposed to parathyroid hormone in vitro and in vivo.

Authors:  Zu-Feng Sun; Hui Jiang; Zheng-Qin Ye; Bing Jia; Xiao-le Zhang; Ke-Qin Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

9.  Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.

Authors:  Glenda J Pettway; Jeffrey A Meganck; Amy J Koh; Evan T Keller; Steven A Goldstein; Laurie K McCauley
Journal:  Bone       Date:  2007-12-15       Impact factor: 4.398

10.  Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.

Authors:  Shilpa Choudhary; Hechang Huang; Lawrence Raisz; Carol Pilbeam
Journal:  Biochem Biophys Res Commun       Date:  2008-05-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.